Notes
The details of a further patient from this study have already been summarised [see Reactions 1440 p23; 803083597].
Reference
Voskens CJ, et al. The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network. PLoS One 8: e53745 [17 pages], No. 1, 14 Jan 2013. Available from: URL: http://dx.doi.org/10.1371/journal.pone.0053745 - Germany
Rights and permissions
About this article
Cite this article
Ipilimumab. Reactions Weekly 1455, 21 (2013). https://doi.org/10.1007/s40278-013-3639-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-013-3639-z